Skip to content

Academic Myeloma Consortium (AMyC)

Collaboration & Innovation in Cancer Research

The Academic Myeloma Cancer Consortium (AMyC) is represented by Key Opinion Leaders (KOLs) and Top Investigators at the most prestigious institutions in the USA. 
It brings together an expert team of institutions and investigators to design and rapidly complete clinical trials with the ultimate goal of identifying new drugs to treat this disease.

"AMyC fills a critical need for pharmaceutical sponsors, providing an unparalleled level of strategic, scientific, and operational expertise in a timely manner."

Brian G.M. Durie, MD, AMyC Director
Academic Myeloma Consortium (AMyC)